GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Beginning Cash Position

Y-Biologics (XKRX:338840) Beginning Cash Position : ₩20,535 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Beginning Cash Position?

Y-Biologics's Beginning Cash Position for the quarter that ended in Mar. 2024 was ₩20,535 Mil.

Y-Biologics's quarterly Beginning Cash Position declined from Sep. 2023 (₩10,931 Mil) to Dec. 2023 (₩9,952 Mil) but then increased from Dec. 2023 (₩9,952 Mil) to Mar. 2024 (₩20,535 Mil).

Y-Biologics's annual Beginning Cash Position increased from Dec. 2020 (₩25,517 Mil) to Dec. 2021 (₩33,389 Mil) but then declined from Dec. 2021 (₩33,389 Mil) to Dec. 2022 (₩16,873 Mil).


Y-Biologics Beginning Cash Position Historical Data

The historical data trend for Y-Biologics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Beginning Cash Position Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beginning Cash Position
Get a 7-Day Free Trial 1,593.47 33,875.68 25,516.88 33,389.08 16,872.73

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only 12,613.66 11,382.17 10,930.59 9,952.13 20,535.47

Y-Biologics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Y-Biologics Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Y-Biologics (XKRX:338840) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines